Stage Iia Iib 3 Cm Seminoma clinical trials

Explore recruiting stage iia iib 3 cm seminoma clinical trials.

Recruiting stage iia iib 3 cm seminoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Stage Iia Iib 3 Cm Seminoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

EDEN : Prospective therapeutic de-escalation and miRNA-M371 biomarker evaluation Phase II study for stage IIa/IIb < 3 cm seminomas

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Stage Iia Iib 3 Cm Seminoma trials by city

Stage Iia Iib 3 Cm Seminoma in Toronto Stage Iia Iib 3 Cm Seminoma in Vancouver Stage Iia Iib 3 Cm Seminoma in Montreal Stage Iia Iib 3 Cm Seminoma in Calgary Stage Iia Iib 3 Cm Seminoma in Edmonton Stage Iia Iib 3 Cm Seminoma in Ottawa Stage Iia Iib 3 Cm Seminoma in Winnipeg Stage Iia Iib 3 Cm Seminoma in Quebec City Stage Iia Iib 3 Cm Seminoma in Hamilton Stage Iia Iib 3 Cm Seminoma in Kitchener Stage Iia Iib 3 Cm Seminoma in London Stage Iia Iib 3 Cm Seminoma in Halifax Stage Iia Iib 3 Cm Seminoma in New York Stage Iia Iib 3 Cm Seminoma in Los Angeles Stage Iia Iib 3 Cm Seminoma in Chicago Stage Iia Iib 3 Cm Seminoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease